PACTR201712002777310尚未招募未知
Changes in Glycemic and Inflammatory status of Type2 Diabetes after Antiviral Therapy for HCV Genotype 4 Patients
none0 个研究点目标入组 90 人开始时间: 2017年11月17日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
- 入组人数
- 90
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 22 Year(s) 至 65 Year(s)（—）
- 性别
- All
入选标准
- •100 Patients diagnosed with type 2 diabetes and HCV-GT4 and treated with two direct antiviral agents (DAAs) will be follow up at 1-baseline, 2-after treatment(12 wks) and 3-12 wks after the end of treatments
排除标准
- •Patients with other infectious diseases, autoimmune disorders, asthma, eczema, allergies, thyroid diseases, kidney failure, liver decompensation and alcohol abuse will be excluded from the study.
研究者
相似试验
已完成
不适用
A clinical trial to study the effect of lifestyle interventions-yoga, diaphragmatic breathing and diet rich in antioxidants on oxidative stress and inflammation in type 2 diabetes mellitusCTRI/2011/05/001739DrShreelaxmi Vijay Hegde238
进行中（未招募）
不适用
EFFECT OF RECOMBINANT HUMAN INSULIN-LIKE GROWTH FACTOR-I ON GLUCOSE TOLERANCE AND AS PREVENTION TOWARDS THE DEVELOPMENT OF CYSTIC FIBROSIS RELATED DIABETES MELLITUSEUCTR2011-002719-27-ITAZIENDA OSPEDALIERA DI PARMA20
已完成
不适用
The ACROSS-China trialISRCTN69559777Bayer (China) Limited4,000
暂停
不适用
The effect of immune function changes by glycemic control with (STG-55) artificial pancreas during heart surgeryheart diseasesJPRN-UMIN000012614Kyushu University40
已完成
4 期
The Study of Glycemic Index of NEO-MUNEglycemic index of NEO-MUNE (medical food for patients who need high protein and high calories)TCTR20170906002Thai Otsuka Pharmaceutical Co., Ltd.10